One Global Service Provider Ltd
Incorporated in 1992, One Global Service
Provider Ltd is in the business of healthcare services[1]
- Market Cap ₹ 1,100 Cr.
- Current Price ₹ 564
- High / Low ₹ 790 / 244
- Stock P/E 14.9
- Book Value ₹ 72.3
- Dividend Yield 0.00 %
- ROCE 87.0 %
- ROE 65.3 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company is expected to give good quarter
- Company has delivered good profit growth of 97.2% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 59.1%
Cons
- Stock is trading at 7.81 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 159 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 2 | 0 | 4 | 6 | 18 | 63 | 147 | 498 | 513 | |
| 0 | 0 | 0 | 0 | 2 | 0 | 1 | 5 | 16 | 53 | 122 | 405 | 414 | |
| Operating Profit | -0 | -0 | -0 | 0 | 0 | -0 | 2 | 1 | 2 | 10 | 25 | 93 | 99 |
| OPM % | 73% | 14% | 68% | 23% | 9% | 15% | 17% | 19% | 19% | ||||
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Profit before tax | -0 | -0 | -0 | 0 | 0 | -0 | 2 | 1 | 1 | 10 | 25 | 93 | 99 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -3% | -1% | 25% | 26% | 25% | |
| -0 | -0 | -0 | 0 | 0 | -0 | 2 | 1 | 1 | 7 | 18 | 70 | 74 | |
| EPS in Rs | -0.14 | -0.11 | -0.13 | 0.27 | 0.38 | -0.42 | 3.28 | 1.48 | 1.94 | 10.01 | 26.00 | 35.56 | 37.84 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 10% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 167% |
| 3 Years: | 202% |
| TTM: | 162% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 97% |
| 5 Years: | 97% |
| 3 Years: | 269% |
| TTM: | 181% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 57% |
| 5 Years: | 101% |
| 3 Years: | 144% |
| 1 Year: | 115% |
| Return on Equity | |
|---|---|
| 10 Years: | 53% |
| 5 Years: | 56% |
| 3 Years: | 59% |
| Last Year: | 65% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 20 | 20 |
| Reserves | -5 | -5 | -5 | -5 | -4 | -5 | -2 | -1 | 0 | 7 | 52 | 122 |
| 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 2 | 1 | 0 | 1 | 2 | 5 | 17 | 34 | 114 | |
| Total Liabilities | 3 | 3 | 3 | 5 | 4 | 3 | 6 | 8 | 13 | 32 | 106 | 255 |
| 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 2 | |
| CWIP | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 2 | 1 | 0 | 3 | 5 | 9 | 28 | 104 | 253 | |
| Total Assets | 3 | 3 | 3 | 5 | 4 | 3 | 6 | 8 | 13 | 32 | 106 | 255 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0 | -0 | -0 | -0 | 0 | -0 | 1 | 1 | 0 | 1 | 14 | 3 | |
| 0 | 0 | 0 | 0 | 0 | 0 | -1 | -1 | -0 | -0 | -0 | -0 | |
| 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | -1 | -0 | |
| Net Cash Flow | -0 | 0 | -0 | -0 | 0 | 0 | 0 | -0 | -0 | 1 | 14 | 2 |
| Free Cash Flow | -0 | -0 | -0 | -0 | 0 | -0 | -0 | -0 | -0 | 1 | 14 | 3 |
| CFO/OP | 90% | 162% | 111% | -32% | 141% | 6% | 45% | 38% | 8% | 12% | 67% | 10% |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 365 | 149 | 0 | 242 | 164 | 152 | 134 | 159 | ||||
| Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
| Days Payable | 98 | |||||||||||
| Cash Conversion Cycle | 365 | 149 | 0 | 242 | 164 | 152 | 134 | 60 | ||||
| Working Capital Days | 421 | 37 | 149 | 135 | 76 | 57 | 59 | 77 | ||||
| ROCE % | -4% | -3% | -3% | 6% | 9% | -11% | 60% | 18% | 20% | 85% | 56% | 87% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sale of Services as % of Total Revenue % |
|
|||||||||
| Number of Permanent Employees count |
||||||||||
| Healthcare Services Share of Total Turnover % |
||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Please find attached copies of Newspaper publications with respect to the Unaudited Standalone Financial Results of the Company, for the quarter ended June 30, 2026
-
Announcement under Regulation 30 (LODR)-Change in Management
- Board approved Q1 FY27 results, appointed CA Niraj Chordia as CFO from 14 Aug 2026.
-
Unaudited Standalone Financial Results For Quarter Ended 30Th June, 2026.
- Board approved Q1 FY27 results, appointed CA Niraj Chordia CFO, and noted auditor changes on 14 Aug 2026.
-
Board Meeting Outcome for Outcome Of Board Meeting For Unaudited Financial Results For The Quarter Ending 30Th June, 2026.
- Board approved Q1 FY27 standalone results, appointed CFO Niraj Chordia, and reappointed cost auditor on 14 Aug 2026.
-
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations, 2015
- Board meeting on August 14, 2026 to approve Q1 FY2027 unaudited results.
Annual reports
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
-
Annual Report 2011
from bse
Business Overview:[1]
a) OGSPL provides services in Life Sciences and Healthcare Solutions across the globe.
b) Company has expertise in mass
screening, diagnostics and healthcare sciences used by hospitals, healthcare professionals and government bodies.
d) Company has started providing consultancy and development in software
and other IT solutions
e) It provides a single online platform
with healthcare products ranging from
medical devices to medical consumables.